Skip to main content
. 2020 Mar 24;74(2):463–472. doi: 10.3233/JAD-191134

Table 1.

Characteristics of the total study sample and according to cSVD score

Variable Total cSVD 0 cSVD 1 cSVD 2 cSVD 3/4 *p-value
n 82 18 20 21 23
Age (y) 71.2±7.9 64.7±7.8 68.9±5.5 73.6±5.6 76.2±7.6 <0.001
Sex (% female) 28 (34.1) 5 (27.8) 7 (35.0) 9 (42.9) 7 (30.4) 0.758
Living with spouse (%) 60 (73.2) 14 (77.8) 18 (90.0) 12 (57.1) 16 (69.6) 0.113
Education (y) 11.0±2.8 10.9±2.8 11.7±2.8 11.6±3.4 11.3±2.9 0.771
BMI (kg/m2)** 25.7±4.1 27.3±5.4 27.1±4.2 23.8±3.2 24.9±3.0 0.031
History of CVD (%) 24 (29.3) 8 (44.4) 7 (35.0) 5 (23.8) 4 (17.4) 0.242
Diabetes (%) 10 (12.2) 2 (11.1) 1 (5.0) 1 (4.8) 6 (26.1) 0.102
Current smoking (%) 12 (14.6) 4 (22.2) 0 5 (23.8) 3 (13.0) 0.126
Antihypertensives (%) 40 (48.8) 10 (55.6) 8 (40.0) 8 (38.1) 14 (60.9) 0.354
Diagnosis (%) 0.039
  Dementia 38 (46.3) 5 (27.8) 6 (30.0) 10 (47.6) 17 (73.9)
  MCI 28 (34.1) 7 (38.9) 7 (35.0) 10 (47.6) 4 (17.4)
  SCI 14 (17.1) 5 (27.8) 6 (30.0) 1 (4.8) 2 (8.7)
  Other 2 (2.4) 1 (5.6) 1 (5.0) 0 0
MR scanner (% 3T)*** 32 (39.0) 6 (33.3) 8 (40.0) 9 (42.9) 9 (39.1) 0.944
CSVD markers (%)
  Lacune(s) 27 (32.9) 2 (10.0) 6 (28.6) 19 (82.6)
  WMH 40 (48.8) 5 (25.0) 14 (66.7) 21 (91.3)
  CMB 26 (31.7) 5 (25.0) 4 (19.0) 17 (73.9)
  ePVS 45 (54.9) 8 (40.0) 18 (85.7) 19 (82.6)

Results are presented as mean±standard deviation or number (frequency). cSVD, cerebral small vessel disease; BMI, body mass index; CVD, cardiovascular disease; MCI, mild cognitive impairment; SCI, subjective cognitive impairment; WMH, white matter hyperintensities; CMB, cerebral microbleeds; ePVS, enlarged perivascular space. * Resulting from univariate analysis of variance (continuous variables) or chi-square test (categorical variables). **Available for n = 69. ***Those not scanned on the 3T scanner were scanned on the 1.5T scanner.